Voloridge Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.11M | Buy |
|
|||||
|
2025
Q1 | $5.55M | Sell |
|
|||||
|
2024
Q4 | $11M | Sell |
|
|||||
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $26.4M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.06M | Sell |
|
|||||
|
2023
Q2 | $13.1M | Buy |
|
|||||
|
2023
Q1 | $4.37M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $7.34M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3.73M | Sell |
|
|||||
|
2021
Q4 | $3.6M | Sell |
|
|||||
|
2021
Q3 | $11.5M | Buy |
|
|||||
|
2021
Q2 | $9.78M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $452K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $513K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $230K | Buy |
|